Aura Biosciences's current cash is $85M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), AURA shows a current cash of $85M. That compares with $38M in the prior-year period — up 121.8% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, AURA's current cash is now $85M (was $38M) — a 121.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Aura Biosciences is outperforming or lagging.
Tracking AURA's current cash over time shows whether Aura Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $85M That compares with $38M in the prior-year period — up 121.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current cash page, Stockcircle has Aura Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $85M) with ownership activity and broader fundamentals.